# FDA Program Aims to Speed Global Drug Access > FDA launches a program letting foreign regulators rely on its reviews, starting with an HIV drug tentative approval. - URL: https://www.lifeconverted.com/learn/fda-program-aims-to-speed-global-drug-access - Category: Research News - Author: Tom Gallagher, Senior Editor - Published: 2026-11-18 - Reading time: 1 min - Keywords: FDA Program Aims to Speed Global Drug Access --- The FDA has introduced the Global Reliance Disclosure Program, a regulatory mechanism intended to help other countries' health authorities use the agency's own review findings instead of repeating full independent evaluations. According to [the FDA's announcement](https://www.fda.gov/news-events/press-announcements/fda-launches-global-reliance-disclosure-program-expand-patient-access-medicines-worldwide), the program allows the agency to share minimally redacted approval packages with companies, who can then pass them to regulators abroad. Each foreign authority still makes its own final decision, so this is a information sharing arrangement, not a transfer of approval authority. The program began on October 30 with a PEPFAR tentative approval for lenacapavir, a drug used for HIV prevention and treatment. Right now it only covers PEPFAR tentative approvals, but the FDA says it plans to expand eligibility in January 2027 to cover new molecular entity applications and biologics license applications more broadly, and to add a faster pathway for already marketed products in early 2027. For readers tracking the regulatory side of research compounds, this is a procedural change in how approval documentation moves between agencies, not a new clinical finding or an approval of any peptide or investigational product. It is worth watching because it could shorten the gap between an FDA decision and access decisions made elsewhere. *This article is for education only. It is not medical advice. Compounds discussed here are sold for research purposes. Talk to a licensed clinician before making health decisions.* ## Sources - FDA Drugs: https://www.fda.gov/news-events/press-announcements/fda-launches-global-reliance-disclosure-program-expand-patient-access-medicines-worldwide --- Published by LifeConverted, https://www.lifeconverted.com/learn/fda-program-aims-to-speed-global-drug-access